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Traditional knowledge (TK) based medicines have gained worldwide attention and
presently the scientific community is focussing on proper pharmacological validation
and identification of lead compounds for the treatment of various diseases. The North
East region of India is the home of valuable traditional herbal remedies. Garcinia morella
Desr. (Guttiferae) is one such medicinal plant used by traditional healers for the treatment
of inflammatory disorders. The present study was aimed to evaluate the antioxidant and
anticancer activity of methanol extracts of the leaf, bark and fruit of G. morella (GM) in
different in vitro and in vivo experimental conditions. The results of this study showed
that GM methanol extracts possessed in vitro antioxidant and anticancer properties,
where the fruit extract (GF) showed maximum activity. The anticancer activity was
further confirmed by the results of in vivo administration of GF (200 mg/kg) for ten
days to Dalton’s lymphoma (DLA) induced mice. GF extract significantly increased the
mean survival time (MST) of the animals, decreased the tumor volume and restored the
hematological and biochemical parameters. The present study for the first time reported
the anticancer property of GF on DLA. Further from the experiments conducted to
elucidate the mechanism of action of GF on DLA, it can be concluded that GF exerts its
anticancer effect through induction of caspases and DNA fragmentation that ultimately
leads to apoptosis. However, further experimentation is required to elucidate the active
principle and validate these findings in various in vivo settings.
Keywords: Dalton’s lymphoma, antioxidant, cytotoxicity, apoptosis, caspase3
INTRODUCTION
Cancer is a leading cause of death worldwide accounting for 8.2 million deaths in 2012 (Ferlay et al.,
2015). The American Cancer Society estimates that around one and half million new cancer cases
are expected to be diagnosed Siegel et al. (2015) in the United States alone. Lymphomas are a type
of cancer that aﬀects the bone marrow, blood cells, lymph nodes, and other parts of the lymphatic
system. According to GLOBACON 2012 (WHO), non-hodgkin’s lymphoma is one of the ten most
diagnosed cancers in men around the world.
Chemotherapy is the common treatment for cancer, but often it is associated with poor quality
of life for the cancer patients, primarily due to treatment related side eﬀects (Lotﬁ-Jam et al., 2008).
To minimize the side eﬀects of the synthetic drugs, the scientiﬁc community is now focussing
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largely on natural product derived drugs (Kunnumakara et al.,
2005; Kuete and Eﬀerth, 2010). So far, more than 25,000
diﬀerent phytochemicals have been identiﬁed that may have
potential against various cancers (Anand et al., 2008). More
than 25% of the drugs that have come in market during
the last 20 years are plant-derived (Amin et al., 2009) some
of the notable ones being vincristine, vinblastine, etoposide,
paclitaxel, curcumin, and campothecine. In India, traditional
medicine systems continue to be widely prevalent. Chemical
investigation of Indianmedicinal plants has the potential to lay an
invaluable foundation for the discovery and development of new
drugs of natural origin (Balunas and Kinghorn, 2005). However,
evidence based determination of the pharmacological properties
of many such medicinal plants remains poorly studied. Scientiﬁc
validation of medicinal plants used by traditional practioners is a
vital part of ethnopharmacology (Shajib et al., 2015).
Garcinia morella Desr. belongs to Guttiferae family and is a
large genus of polygamous trees or shrubs, distributed in the
tropical Asia, Africa and Polynesia. Garcinia species are a rich
source of secondary metabolites including xanthones, ﬂavonoids,
benzophenones, lactones, and phenolic acids (Gustafson et al.,
1992). The Garcinia species of plants are well known for their
antibacterial (Rao and Verma, 1951; Sani and Rao, 1969) anti-
inﬂammatory, antioxidative (Yamaguchi et al., 2000) antifungal
activities etc (Gopalakrishnan et al., 1997). Xanthones and
prenylated benzophenones isolated from Garcinia have shown to
be cytotoxic (Mackeen et al., 2000; Huang et al., 2011;Wang et al.,
2012; Li et al., 2013a) against diﬀerent human cancer cell lines
in both in vitro and in vivo studies. Chemical constituents like
morelloﬂavone, guttiferic acid, and gambogic acid were reported
from G. morella plant (Karanjgaokar et al., 1967; Rajagopal Rao
et al., 2007; Chantarasriwong et al., 2010). G. morella locally
known as kuji thekera is a medicinal plant used by the locals and
tribal people of the north eastern region of India to cure stomach
ailments, bowel disorders and inﬂammatory diseases. However,
there is no scientiﬁc validation of G. morella fruits being used
against Dalton’s lymphoma ascites tumour (DLA). DLA is a
T-cell lymphoma originating spontaneously in the thymus of
DBA (H2D) strain of mice (Klein, 1951; Deepak et al., 2007). It has
been noticed that spontaneously arising animal tumors mimic a
situation more similar to human neoplasia than experimentally
induced tumors (Ben-Efraim et al., 1999). Therefore, we aimed
to evaluate the antioxidant and anticancer activities of G. morella
(GM)methanol extracts againstDLA tumormodels and elucidate
the probable molecular mechanism of action.
MATERIALS AND METHODS
Chemicals and Reagents
2,2-Diphenyl-picrylhydrazyl (DPPH), butylated hydroxyl
toluene (BHT), tris (hydroxymethyl) aminomethane (Tris),
ethylenediamine tetraacetic acid (EDTA), potassium ferricyanide,
trichloroacetic acid, thiobarbituric acid, trypan blue, propidium
iodide, 3-(4,5-dimethylthiozol-2-yl)-2,5 diphenyltetrazolium
bromide dye (MTT) were purchased from Sigma–Aldrich., USA.
Aspartate transaminase (AST), Alanine aminotransferase (ALT),
and Alkaline phosphatase (ALP) kits were purchased from
Accurex, India. Remaining chemicals used in this study were
analytical grade and procured either from Sigma–Aldrich, USA
or Merck, Germany.
Plant Collection and Identification
Fresh fruit, leaves, and bark of G. morella were collected from
Barpeta district of Assam, India in the month of February.
Plant materials were authenticated by taxonomist at North
East Indian Ayurvedic Research Institute (Government of
India) Guwahati, Assam, India. Herbarium was prepared and
voucher specimen numbers (IASST/BCCS/HNO112/2012,
IASST/BCCS/HNO114/2012, IASST/BCCS/HNO115/2012)
were deposited in Drug Discovery Laboratory, Institute of
Advanced study in Science and Technology, Guwahati, Assam,
India.
Preparation of Extracts
The leaf, bark, and fruit of the plant was washed, chopped
into small pieces and dried under shade. Dried samples were
grounded to powder and extracted using 1000 ml methanol
by maceration with continuous stirring for 3 days at room
temperature (25 ± 2◦C). This extraction was repeated three
times. The extracts were ﬁltered through Whatman ﬁlter paper to
separate the solvent and marc. Final extracts were concentrated
through vacuum evaporation (Buchi R-300, USA) at 45◦C and all
dried extracts were stored in tightly closed containers at −20◦C
until used for pharmacological testing (Sowemimo et al., 2015).
Measurement of In Vitro Antioxidant
Activity
DPPH Free Radical Scavenging Assay
2,2-Diphenyl-picrylhydrazyl free radical scavenging activity was
determined by following (Sarwar et al., 2015). Brieﬂy, 2.7 ml of
0.2 mM DPPH in methanol solution was added to 0.3 ml of the
sample solutions. The reaction mixture was shaken and incubated
at room temperature for 1 h and absorbance was measured at
517 nm. The radical scavenging activity was calculated by using
following formula-
Scavenging rate = {(As − Ai)/As} × 100
Where As is the absorbance of pure DPPH and Ai is the
absorbance of DPPH in the presence of various samples. In this
assay BHT was used as standard.
Reducing Power Assay
The reducing power of the extracts was measured by the method
of Oyaizu (1986). Brieﬂy, various concentrations of 0.2 ml of
samples were mixed with 2.5 ml phosphate buﬀer (0.2 M, pH 6.6)
and 2.5ml of 1% potassium ferricyanide. After incubation at 50◦C
for 20 min, 2.5 ml trichloroacetic acid (10%) was added and each
reaction mixture was centrifuged at 100 rpm for 10 min. Then
2.5 ml supernatant was collected and mixed with 2.5 ml water
and 0.5 ml ferric chloride (0.1%). The absorbance was measured
at 700 nm. The increased absorbance of the reaction mixture
indicated increased reducing power. BHTwas used as a standard.
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Lipid Peroxidation Inhibition Assay
Lipid peroxidation inhibition activity of the extracts was
determined by thiobarbituric acid (TBA) assay of (Badmus et al.,
2011). This assay is based on the reaction of the end product
of lipid peroxidation, malondialdehyde (MDA) with TBA to
form an adduct, a pink chromogen. Brieﬂy, 0.1 ml of 100 μg/ml
methanol extracts was added to 400 μl of double distilled water,
50 μL FeSO4 and 500 μl of 10% egg yolk. This reaction mixture
was incubated for 30 min at 37◦C, further 1.5 ml of 0.8% TBA
in 1.1% SDS and 1.5 ml of 20% TCA was added. The reaction
mixture was incubated for 1 h at 95◦C, immediately cooled
and 2 ml of butanol was added. The total reaction mixture was
centrifuged at 3000 rpm for 5 min. The absorbance of the organic
layer was measured at 532 nm. The percentage lipid peroxidation
inhibition (LPI %) was calculated using the following
formula:
LPI% = [(AC − AS)/AC] × 100
AC = control absorbance, AS = sample absorbance
In Vitro Anticancer Screening of GM
Methanol Extracts
MTT Assay
Evaluation of cytotoxicity of the extracts on DLA cells was done
by MTT assay. DLA cells were harvested in RPMI 1640 medium
(10% FBS and antibiotic solution) and seeded in 96 well culture
plate with diﬀerent concentrations of the extracts. The culture
plates were incubated for 3 h at 37◦C and 5% CO2. After the
incubation period, 10 μl MTT (4 mg/ml) was added to the wells
and the plates were incubated in dark for 3 h. The formazan
formed in wells was dissolved in 100 μl of DMSO and OD was
measured at 570 nm.
Trypan Blue Assay
In vitro cytotoxic activity of the extracts on DLA cells was
determined by trypan blue dye exclusion assay (Anjana et al.,
2014). This dye is impermeable to live cells but enters the
compromised membranes of dead cells. Brieﬂy 1 × 106 DLA
cells in 1ml RPMI1640 media was incubated with diﬀerent
concentrations of the extracts for 3 h. After incubation cells
were centrifuged and the pellet was resuspended in 0.5 ml
of RPMI1640 media. 50 μl of cell suspension was mixed
with equal amount of 0.4% trypan blue and the cells were
counted using cell counter (Countess II FL, Life Technologies,
USA). The percentage of cell cytotoxicity was determined as
follows:
% Cell cytotoxicity =
100 − Number of viable cells in the treated group
Number of viable cells in the untreated control group
× 100
Cell Cytotoxicity by FACS Analysis
After incubation of 1 × 106 DLA cells with diﬀerent
concentrations of the extracts for 3 h at 37◦C, cells were washed
with PBS and stained with 500μl propidium iodide (PI) (1 mg/ml
PI solution) to observe the percentage of cell death by FACS (BD
Biosciences, USA) and the results were analyzed by using BD
FACSuiteTM.
Effect of GF Methanol Extract on
Apoptosis of DLA Cells
Caspase3 Assay
The levels of caspase3 in DLA cells on treatment with GF
methanol extract was evaluated by using a caspase3 colorimetric
assay kit (Catalog No: B3100) (R&D Systems, USA) (Xie et al.,
2012). Brieﬂy, 2 × 106 DLA cells were incubated with 150 μg/ml
and 250 μg/ml of GF extract for 3 h at 37◦C. A control set
without treatment was also kept in the same condition. After
treatment the cells were washed with ice cold PBS and lysed
with ice cold lysis buﬀer given in the kit. Assay procedure was
followed according to the instructions given by the manufacturer.
Absorbance of the plate was recorded at 405 nm in multimode
reader (Thermo Scientiﬁc, USA).
Effect of GF Methanol Extract on DLA
Cell Morphology
Acridine Orange and Ethidium Bromide (AO/EB)
Assay
Dalton’s Lymphoma cells treated with diﬀerent doses of
GF methanol extract were stained with AO/EB to observe
morphological changes (Pajaniradje et al., 2014; Prasad and Koch,
2014). Brieﬂy freshly aspirated DLA cells were washed twice with
PBS (pH 7.4) and counted under inverted microscope. Viable
cells were determined by staining with trypan blue 1 × 106 cells
were incubated with diﬀerent concentrations of the extracts for
3 h at 37◦C. After the incubation period, the cells were washed
with PBS and stained with 20 μl of 100 μg AO/EB and observed
under ﬂuorescent inverted microscope.
Scanning Electron Microscope (SEM)
Analysis
After incubation of DLA cells with 150 μg/ml and 250 μg/ml of
GF methanol extract, cells were observed under SEM (Carl Zeiss,
SIGMAVP, Japan) to observe the cell morphology.
Effect of GF Methanol Extract on DNA
Fragmentation
DNA fragmentation assay was carried out by incubating 1 × 107
cells with 50, 100, 150, and 200 μg/ml of GF methanol extract
for 3 h in RPMI1640 at 37◦C and 5% CO2. After incubation
cells were washed twice with cold PBS and centrifuged, the cell
pellet was lysed with lysis buﬀer (20 mM Tris HCl pH 8, 5 mM
EDTA, 40 mM NaCl, and 1% SDS) on ice for 30 min. The lysate
obtained was centrifuged and the supernatant was separated.
To the supernatant 20 mg/ml proteinase K was added and the
reaction mixture was incubated at 37◦C for 2 h. The DNA was
precipitated with absolute ethanol and 5 M NaCl overnight at
−20◦C. The DNA pellet was washed with 70% ethanol, air dried
and dissolved in 1 × Tris-EDTA buﬀer. Electrophoresis was
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performed for the DNA obtained from each set in 1.8% agarose
gel containing 0.5 μg/ml ethidium bromide. 200 bp DNAmarker
was run in the same gel (Prasad and Koch, 2014).
Acute Toxicity Study
OECD guidelines were followed to conduct acute toxicity studies.
Swiss albino mice of either sex were selected for this study.
Animals were kept overnight fasting with free access to water
and after 12 h, single oral dose of GF, GB, and GL at 2000 mg/kg
body weight were administered to three animals. All the animals
were observed for 14 days to check for mortality, if mortality was
observed in 2 out of 3 animals, then the dose was identiﬁed as
toxic dose. If mortality was observed in one animal, experiment
was repeated again with same dose to conﬁrm the toxic dose.
If mortality observed again experiment was continued with low
doses 300, 50, and 5 mg/kg body weight by following Ecobichon
(1997).
In Vivo Anticancer Activity of GF, GB, GL
Methanol Extracts on DLA in Mouse
Animals
Male Swiss albino mouse weighing 22–25 g were procured from
Pasteur Institute, Shillong and housed at Institute of Advanced
Study in Science and Technology (IASST), Guwahati, Assam.
Animals were acclimatized in polypropylene cages and fed with
rodent pellet diet (Provimi Animal Nutrition India Pvt. Ltd.,
India) and water ad libitum. Temperature 22 ± 2◦C, relative
humidity 60–70%, and 12–12 h light–dark cycle was maintained
throughout the experimental period and all experiments
were performed during 9–14 h. The experimental protocol
was approved (IASST/IAEC/2013–14/556) by the Institutional
Animal Ethics Committee (IAEC) of IASST, Guwahati before
starting the experiments and performed according to guidelines
of Committee for Control and Supervision of Experimentation
on Animals (CPCSEAs), Government of India.
Dalton’s Ascites Lymphoma Cells
Dalton’s ascites lymphoma (DLA) cells were kindly gifted by
Dr. Surya Bali Prasad, NEHU, Department of Zoology, Shillong,
India. Cells were maintained by intraperitoneal inoculation of
2 × 106 cells/mouse.
Animal Grouping and Treatment Schedule
A total of seventy animals were divided into seven groups
(n = 10). All the animals were injected with DLA cells (0.2 mL of
2 × 106 cells/mouse) intraperitoneally, except the normal group,
for the development of ascites tumor (Kuttan et al., 1988). The
drug treatments were started subsequently by dissolving in 0.3%
CMC and administered orally to the animals at 24 h intervals for
10 days.
Group I : Normal animals without inoculation with DLA cells.
Group II : DLA animals + Vehicle control (0.3% CMC)
Group III : DLA animals + 10 mg/ kg Cyclophosphamide
Group IV : DLA animals + 100 mg/kg GF methanol extract
Group V : DLA animals + 200 mg/kg GF methanol extract
Group VI : DLA animals + 200 mg/kg GL methanol extract
Group VII : DLA animals + 200 mg/Kg GB methanol extract
Effect of the Extracts on Tumor Growth
The anticancer activity of the extracts were evaluated by analysis
of diﬀerent parameters like median survival time (MST) of each
group (n = 10), % increase in life span (ILS) of the animals,
changes in body weight and viable cell count. MST of each
group was calculated with reference to the negative control group
(Group-II) and anticancer activity of the drugs was determined
by evaluating its ability to increase the life span of the DLA
induced animals (Gupta et al., 2000). MST and % ILS were
calculated by using the following formulae-
Mean survival time = [ﬁrst Death + Last Death]/2
Increase of life span ILS (%) =
Mean survival of treated group (T)
Mean survival of control untreated group (C)
× 100
Where T = number of days treated animals survivedC= number
of days control animals survived
The survival curve was plotted using Kaplein–Meier method
(Ghosh and Maiti, 2007; Kant et al., 2014) (Figure 3).
Hematological Parameters
At the end of experimental period, animals were sacriﬁced and
blood was collected in EDTA coated tubes for estimation of red
blood cells (RBC), white blood cell (WBC) and hemoglobin (Hb)
by standard procedures (Rajesh et al., 2011).
Biochemical Parameters
Twenty 4 h after the last drug treatment, animals were sacriﬁced.
Blood was collected immediately in tubes without anticoagulant
and centrifuged at 3000g at 4◦C for 10 min to separate the
serum. Blood free serum was used for evaluating biochemical
parameters such AST, ALT, and ALP levels (Priya et al., 2011) by
using commercially available kits (Accurex, India) according to
manufacturer’s instructions.
Neo Vascularisation
After sacriﬁcing the animals on the 10th day the peritoneum of
the mice were removed and the inner lining of the peritoneum
were observed for angiogenesis. Photographs of the peritoneal
linings were captured (Augustine et al., 2014).
Histopathological Analysis
Liver tissues were immediately ﬁxed in 10% buﬀered formalin,
embedded in paraﬃn, processed by means of routine histological
techniques and stained with haematoxylin and eosin (Priya et al.,
2011) to observe the pathological changes under light contrast
microscope (10X).
Effect of GB, GF, and GL Methanol
Extracts on Dalton’s Lymphoma Cell
Death
Swiss albino mice of weight 25 ± 2 g were divided into ﬁve
groups of six animals in each group. 1 × 106 DLA cells
injected intraperitoneally to the animals for development of DLA
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ascites tumor. After 8 days of tumor development, drug was
administered intraperitoneally for 2 days as follows-
Group-I : DLA mouse + Vehicle treatment (0.3% CMC)
Group-II : DLA mouse +GBmethanol extract (200 mg/kg)
Group-III : DLA mouse + GF methanol extract (200 mg/kg)
Group-IV : DLA mouse + GL methanol extract (200 mg/kg)
Group-V : DLA mouse + Cyclophosphamide (10 mg/kg)
Four hours after the last drug treatment, DLA cells were
aspirated from the animals and washed with PBS, incubated in
500μL PI (1 mg/ml PI solution) for 5 mins and observed in FACS
for detection of cell death. Results were analyzed by using BD
FACSuiteTM. Total experimental procedure was repeated thrice
to conﬁrm the results accurately. Fold change in % cell death was
calculated by the formula-
Fold change = %cell death in treated group
% cell death in untreated (control) group
The PI stained cells were also observed under ﬂuorescent
microscope to mark the morphological changes in nuclei of DLA
cells aspirated from treated groups in comparison to the vehicle
control group.
Statistical Analysis
All the results are expressed in mean ± SD. Experimental data
was analyzed by one way ANOVA followed by Tukey’s multiple
comparison test was used to compare the diﬀerent parameters
between the groups. A P < 0.05 was considered as signiﬁcant.
The survival study was analyzed by Kaplein–Meier method. All
the statistical analysis was done by using the GraphPad Prism 6
software.
RESULTS
In vitro Antioxidant Assays
GM Extracts Scavenge DPPH Free Radicals
2,2-Diphenyl-picrylhydrazyl is a free radical compound and it is
accepted in estimating the scavenging activity of antioxidants.
The DPPH scavenging activities of diﬀerent extracts are
presented in Figure 1A. The methanol extract of G. morella
fruit, leaf and bark were screened for in vitro antioxidant activity
at diﬀerent concentrations 10, 25, 50, 75, and 100 (μg/ml).
From Figure 1A, the methanol extracts of GM fruit, leaves
and bark have shown high DPPH scavenging activity in a dose
dependent manner. GF extract showed the highest DPPH free
radical scavenging activity in comparison to the GB and GL.
Reducing Power Ability of GM Extracts
Reducing power of a substance is the measure of the antioxidant
capacity of the substance. (Meir et al., 1995). In this assay, the
reducing power of the extracts was determined by measuring
the potentiality of the extracts in reducing Fe3+ to Fe2+. On
formation of Fe2+ the solution turns prussian blue and the
intensity of color formation is directly proportional to Fe2+
formation. The OD of the solutions at 700 nm thus represents the
FIGURE 1 | In vitro antioxidant assays (A) DPPH radical scavenging activity (B) Reducing power activity (C) Lipid peroxidation inhibition activity of
methanol extracts of G. morella fruit (GF), bark (GB), leaf (GL), and standard BHT.
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reducing power of the extracts. From (Figure 1B) the reducing
power of the extract increases on increase in concentration. The
order of reductive potential is thus BHT> GF> GL> GB.
Lipid Peroxidation Inhibition Activity
Lipid peroxidation inhibition ability of diﬀerent extracts of
G. morella is given in (Figure 1C). Among all the extracts GF
methanol extract showed the highest inhibition at 100 μg/ml
which was even higher than the standard BHT.
Treatment with GF Extract Induces Death of DLA
Cells in in vitro Condition
The GF extract has shown cytotoxic activity in a dose dependent
manner on DLA cells as observed from MTT assay, trypan blue
dye exclusion method and FACS analysis (Figure 2). In FACS
analysis (Figure 2C), it was observed that the GF extract exerted
the highest cytotoxic impact on DLA cells. GF methanol extract
150, 250, and 500 μg/ml caused 45.7, 63.2, and 73.9% cell death,
respectively. From the MTT assay the IC50 of GF on DLA cells
was found to be 250 μg/ml (Figure 2A). From trypan blue
dye exclusion method it was observed that GF methanol extract
showed dose dependent increase in % cell death of DLA cells
(Figure 2B).
GF Extract Induces Apoptosis of DLA Cells
GF methanol extract signiﬁcantly increased the caspase3 activity
in DLA cells. Caspase cascade activation plays an important role
in apoptosis. To determine the role of caspases in GF extract
induced apoptosis, the activity of caspase3 was investigated.
Treatment of DLA cells with GF at 150 μg/ml and 250 μg/ml for
3 h dose dependently increased the fold change in caspase3 level
relative to the untreated DLA cells. Treatment with 150 μg/ml
and 250μg/ml GFmethanol extract resulted in 2.35 and 2.72-fold
increase (p < 0.05), respectively, in caspase3 level (Figure 3A) of
DLA cells.
Acridine orange/ethidium bromide staining was done to
observe the morphological changes of the DLA cells upon
treatment with the extracts for 3 h. The cells showing green
ﬂuorescence with intact green nucleus represents live cells in both
control (Figure 4A) and treatment groups (Figures 4B,C). On
treatment with GF 150 and 250 μg/ml distinct morphological
changes were observed in the DLA cells such as cell shrinkage,
blebbing, and more number of orange/red cells (apoptotic cells).
SEM images of the GF treated DLA cells also displayed the
appearance of membrane blebbing which signiﬁed the initiation
of apoptosis (Figures 4E,F) which was completely absent in
control (Figure 4D). To conﬁrm the induction of apoptosis by
FIGURE 2 | In vitro cell viability of DLA cells monitored by (A) MTT assay and (C) FACS analysis after 3 h treatment of DLA cells with different
concentrations of GF, GB, and GL and (B) Trypan blue dye exclusion assay of DLA cells on treatment with GF at different concentrations for 3 h. Data
are shown as % cell death for FACS and trypan blue assay and % inhibition of cell proliferation for MTT assay. % cell death and % inhibition of cell proliferation are
calculated by comparing with the untreated control group. All the results are expressed in mean ± SD (n = 3).
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FIGURE 3 | In vitro apoptotic effect of GF on DLA cells was determined
by (A) fold change in level of caspase3 of DLA cells on treatment with
GF (150 and 250 µg/ml) for 3 h. Fold change is calculated by comparing
with untreated DLA cells. All the results are expressed in mean ± SD (n = 3).
(B) DNA fragmentation in different doses of GF treated DLA cells. 10 μg DNA
from each treatment groups and untreated group was loaded in each lane and
subjected to1.8% agarose gel electrophoresis followed by detection of EtBr
stained DNA bands in UV transilluminator. The photograph is a representative
of three repeats. Here lane1:200 bp DNA ladder, lane2, 3, 4, and 5 represents
DNA of DLA cells treated with 50, 100, 150, and 200 μg/ml GF for 3 h. lane6:
DNA of untreated DLA cells.
GF methanol extract on DLA cells DNA fragmentation assay was
done. DNA of the treated DLA cells was observed to display
laddering pattern, in contrast the untreated cells showed intact
DNA (Figure 3B). On late apoptosis stage, DNA fragments at
an interval of 180–200 bp and DNA band appear like ladder in
the gel. So we could conﬁrm that treatment with GF conferred
apoptotic induction and death in the DLA cells.
Acute Toxicity Study
Acute toxicity study was conducted to determine the toxicity level
of the drug. All the extracts were given at a dose of 2000 mg/kg
to the mice and observed for 14 days. None of the extracts
caused any change in general behavior or lethality to the mice
when observed for 14 days. So 1/10th of non-lethal dose was
selected for in vivo anticancer assay. From in vitro assays it was
observed that GF methanol extract was highly antioxidant and
cytotoxic than GB and GL methanol extracts. Hence two doses
were selected for GF methanol extract (100 and 200 mg/kg)
and only one dose was selected for the remaining two extracts
(200 mg/kg).
Effect of the Extracts on Tumor Growth
GF and GLmethanol extracts were signiﬁcantly cytotoxic to DLA
cells, whereas GB methanol extract did not produce signiﬁcant
activity (Table 1).
The weight of the DLA induced mice gradually increases with
passage of time due to accumulation of ascitic ﬂuid in the belly.
Hence change in weight is considered as a parameter to determine
the intensity of the disease. FromTable 1, it was observed that the
GF and GL methanol extracts at 200 mg/kg caused no signiﬁcant
increase in body weight of the animal, i.e., of about 6.3 and 5.6 gm,
respectively, while in the untreated group of animals the increase
in weight was about 13.5 gm (Figures 7B1,2 ).
Treatment with all the extracts GF, GB, and GL increased the
life span of DLA inducedmice. GFmethanol extract at 200mg /kg
increased the life span of the mice to 66% whereas the standard
drug treated group had a percentage increase ILS of about 132.7
with respect to the untreated group of animals. From the mean
survival time (MST) data also it was evident that the GF could
increase the MST of the DLA induced mice in a dose dependent
manner. As observed from the Kaplan–Meier curve (Figure 5)
GF methanol extract displayed the highest activity in increasing
the longevity of DLA induced mice.
Effect of Drug Treatments on
Hematological Parameter
It was observed that the level of WBC severely raised up for the
DLA induced untreated group of animals whereas the RBC count
and hemoglobin count of these group drastically dropped down
as compared to normal animals (Table 2). Interestingly, GF and
GL extracts could restore the hematological parameters of the
DLA induced mice. The GF and GL extract at 200 mg/kg could
increase the RBC count to 3.67 ± 0.21$$$ and 3.81 ± 0.20$$$
(Cells/ml × 106), respectively, and lowered the WBC count
to 14.20 ± 0.21$$$ and 14.81 ± 0.18$$$ (Cells/ml × 103),
respectively.
Effect of Drug Treatment on Biochemical
Parameters
Inoculation of DLA cells in mice caused signiﬁcant increase in
levels of enzymes such as AST, ALT, and ALP. It was evident that
the treatment with the standard cyclophosphamide could bring
back the serum enzyme levels to the normal range (Table 3). The
GF (200 mg/kg) treated group of animals also had a comparable
range of enzyme levels with normal animals. The eﬀect of the
extracts in restoring the enzyme levels was signiﬁcant.
Effect of Drug Treatment on Neo
Vascularisation
The peritoneum of the DLA induced animals untreated animals
(control) (Figure 6A) showed greater number of blood vessels
than the treatment groups (Figures 6B,C). From the critical
observation of the photographs it can be concluded that
treatment of DLA animals with GF methanol extract at
200 mg/kg and cyclophosphamide (10 mg/kg) signiﬁcantly
inhibited neovascularisation.
Effect of Drug Treatments on Liver
Histopathology
Liver tissue of DLA bearing mice in vehicle treated group
showed degenerative hepatocytes with periportal inﬂammation,
inﬂammatory inﬁltrate is composed mainly of lymphocytes
(Figure 6D). DLA animals treated with standard drug
(Figure 6E) and GF methanol extract (Figure 6F) showed
protection against hepatic damage, even though in case of extract
treated group mild lymphocyte inﬁltration was observed.
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FIGURE 4 | Changes in morphology of DLA cell on treatment with GF was determine by staining untreated and GF treated DLA with AO/EtBr (A–C).
Here (A) is the untreated DLA cells (B) DLA cells treated with 150 μg/ml GF and (C) DLA cells treated with 250 μg/ml GF for 3 h. The white arrows are pointing to
normal live cells, blue arrows are directing toward cells having shrinked nucleus representing early apoptosis and red arrows are pointing toward cells containing
yellowish orange nuclei representing apoptotic cells. (D–F) Scanning electron microscope images of DLA cells afters treatment with GF 150 and 250 μg/ml for 3 h.
(D) Control DLA cells. (E) DLA cells treated with GF 150 μg/ml and (F) DLA cells treated with GF 250 μg/ml for 3 h. Untreated DLA are observed to have smooth
surface but the DLA cells treated with GF extract are shown have many ruptures on the surface.
TABLE 1 | Effect of different drug treatments on In vivo tumor growth.
S.no Treatment Viable tumor cells count (105 Cells/ml) Weight change (gm) MST % ILS
1 DLA 558 ± 7.45 13.5 ± 0.96 12.2 ± 1.28 -
2 DLA + CYLP (10 mg/kg) 9.3 ± 1.22∗∗∗ 5.5 ± 0.02∗∗∗ 28.4 ± 2.12 132.7
3 DLA + GF (100 mg/kg) 62.9 ± 4.17∗∗∗ 8.2 ± 0.74∗∗∗ 16.8 ± 1.72 37.7
4 DLA + GF (200 mg/kg) 22 ± 2.72∗∗∗ 6.3 ± 0.57∗∗∗ 20.3 ± 1.61 66
5 DLA + GB (200 mg/kg) 105.6 ± 4.94∗∗∗ 7.3 ± 0.42∗∗∗ 14.5 ± 1.37 18.85
6 DLA + GL (200 mg/kg) 44.8 ± 3.47∗∗∗ 5.6 ± 0.16∗∗∗ 18.4 ± 1.98 50.8
All the results were expressed in mean ± SD (n = 10). ***P ≤ 0.001 in comparison of drug treated DLA mice with untreated DLA mice. DLA, Dalton’s lymphoma; CYLP,
Cyclophosphamide; GF, G. morella fruit methanol extract; GB, G. morella bark methanol extract; GL, G. morella leaf methanol extract.
In Vivo Apoptotic Induction of DLA Cells
on Treatment with GF
It was observed that GF methanol extract at 200 mg/kg caused
the maximum increase in fold change of % cell death of
approximately 1.98. Whereas in GB, GL methanol extracts and
standard drug treated groups, the fold change of about 0.68, 1.2,
and 1.76 was observed (Figure 7A).
To conﬁrm the induction of apoptotic cell death in DLA
cells, PI staining was done to the cells from diﬀerent treatment
groups. Results showed that DLA cells treated with GF methanol
extract at 200 mg/kg showed prominent apoptotic morphology
(Figures 7C3,4) This observation is comparable with standard
treated group (Figure 7C2), whereas in untreated cells negligible
cell death was observed (Figure 7C1).
DISCUSSION
The results of the present study reports the dose dependent
anticancer activity of G. morella fruit extract on DLA induced
ascites tumor models. The present study also reveals the presence
of strong antioxidant compounds in the methanol extracts of
G.morella fruit, bark and leaf, which was demonstrated by in vitro
DPPH scavenging, reducing power, and lipid peroxidation
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FIGURE 5 | Effect of the G. morella extracts on longevity of DLA
induced mice is represented by Kaplan–Meir curve.
inhibition assays. The experimental results showed that GF
extract possessed strong antioxidant activity than GB and GL
extracts in all the experiments conducted. IC 50 value of GF
in DPPH radical scavenging assay was found to be 50 μg/ml,
which is very low in comparison to the previous report (Gogoi
et al., 2012), where they recorded 303.63 ± 5.34 μg/ml. This
enhancement in activity was might be due to the change in
geographical location, season, and time of collection of fruit
samples. Free radicals are formed naturally in the body and
play important role in cellular processes. However, at higher
concentrations, it can cause hazardous damage to the cellular
components, like DNA, protein, and cell membranes. Damage
especially to the DNA can trigger the development of cancer
(Li et al., 2013b). Studies have revealed that antioxidants
have the ability to save the cells from the damaging eﬀects
of free radicals. Dietary antioxidants, such as lycopene, beta
carotene, alpha tocopherol are known to be used for cancer
chemoprevention and therapy (Gloria et al., 2014; Kim and Kim,
2015).
Several studies have been reported previously, which indicate
that the molecules possessing antioxidant activities can possibly
slow or prevent the development of cancer (Islam et al., 2013).
The results of antioxidant assays therefore inspired us to evaluate
the eﬀects of the GM extracts on cancer cells. The signiﬁcant
anti-proliferative activity of GF with an IC50 of 250 μg/ml
demonstrates its anticancer potential, which was also observed
in FACS analysis where methanol extract of GF at 250 μg/ml
caused 63.2% cell death. Treatment with this extract also resulted
in loss of membrane integrity of DLA cells thereby making trypan
blue dye permeable through the membrane. Similarly, Prasad and
Koch (2014) reported the IC50 ofDendrobium formosum onDLA
cells to be 350 μg/ml.
The subsequent study to understand the underlying molecular
mechanism of GF on DLA revealed that GF induces apoptosis in
DLA cells by activation of caspase cascade and fragmentation of
DNA. Apoptosis is one of the key targets of chemotherapeutic
drugs in cancer therapy. It is a programmed cell death in
which the dead cells are removed without causing inﬂammation
TABLE 2 | Effect of different drug treatments on hematological parameters.
S. no Treatment RBC (Cells/ml X 106) WBC (Cells/ml X 103) Hb g/dl
1 Normal 5.19 ± 0.21 11.23 ± 0.28 14.66 ± 0.20
2 DLA control 2.35 ± 0.18∗∗∗ 17.47 ± 0.31∗∗∗ 7.78 ± 0.13∗∗∗
3 DLA + CYLP (10 mg/kg) 3.92 ± 0.22$$$ 13.43 ± 0.26$$$ 12.36 ± 0.18$$$
4 DLA + GF (100 mg/kg) 3.27 ± 0.18$$$ 15.37 ± 0.19$$$ 10.35 ± 0.17$$$
5 DLA + GF (200 mg/kg) 3.67 ± 0.21$$$ 14.20 ± 0.21$$$ 11.88 ± 0.21$$$
6 DLA + GB (200 mg/kg) 2.71 ± 0.23$$ 16.33 ± 0.22$$$ 8.05 ± 0.14$$
7 DLA + GL (200 mg/kg) 3.81 ± 0.20$$$ 14.81 ± 0.18$$$ 11.28 ± 0.21$$$
All the results were expressed in mean ± SD (n = 10). ***P ≤ 0.001 comparison of DLA untreated mice with normal mice, $$$ P ≤ 0.001 and $$ P ≤ 0.01 comparison of
drug treated DLA mice with DLA untreated mice. DLA, Dalton’s lymphoma; CYLP, Cyclophosphamide; GF, G. morella fruit methanol extract; GB, G. morella bark methanol
extract; GL, G. morella leaf methanol extract.
TABLE 3 | Effect of different drug treatments on serum biochemical parameters.
S.no Treatment AST ALT ALP
1 Control 41.14 ± 2.36 34.18 ± 1.79 128.52 ± 2.21
2 DLA 87.17 ± 3.11∗∗∗ 57.19 ± 2.41∗∗∗ 247.35 ± 3.62∗∗∗
3 DLA + CYLP (10 mg/kg) 49.47 ± 2.62$$$ 42.33 ± 1.87$$$ 147.89 ± 1.68$$$
4 DLA + GF (100 mg/kg) 67.47 ± 3.38$$$ 49.51 ± 2.64$$$ 202.91 ± 2.48$$$
5 DLA + GF (200 mg/kg) 56.92 ± 2.76$$$ 44.58 ± 3.11$$$ 177.77 ± 3.15$$$
6 DLA + GB (200 mg/kg) 73.92 ± 3.61$$ 52.71 ± 2.86$$ 231.09 ± 4.23$
7 DLA + GL (200 mg/kg) 61.46 ± 1.94$$$ 47.96 ± 1.82$$$ 188.24 ± 2.27$$$
All the results were expressed in mean ± SD (n = 10). ***P ≤ 0.001 comparison of DLA untreated mice with normal mice, $$$ P ≤ 0.00, $$ P ≤ 0.01 and $ P ≤ 0.05
comparison of drug treated DLA mice with DLA untreated mice. DLA, Dalton’s lymphoma; CYLP, Cyclophosphamide; GF, G. morella fruit methanol extract; GB, G. morella
bark methanol extract; GL, G. morella leaf methanol extract.
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FIGURE 6 | Effect of drug treatment on neo vascularisation (A–C) and liver histology (D–E). The figures (A–C) represent the inner peritoneum lining of
untreated, standard treated and GF 200 mg/kg treated DLA induced animals, respectively. The blue arrow is indicating new vasculature in the peritoneum of
untreated DLA induced mice. The GF treated and Standard treated animals doesn’t show any significant angiogenesis. (D–F) is the liver histology of DLA induced
untreated, standard treated and GF200 mg/kg treated animals.
and damage to the nearby cells. Apoptosis is characterized
by membrane blebbing, cell shrinkage, chromosomal DNA
fragmentation (Prasad and Koch, 2014). Presence of membrane
blebbing and yellowish/orange condensed chromatin in DLA
cells after treatment with GF extract at diﬀerent doses for 3 h
clearly indicating the apoptotic properties of GF extract in DLA
cells. The SEM images also proved cell membrane blebbing,
which indicates apoptosis of the DLA cells upon treatment with
GF. One of the major biochemical hallmarks of apoptosis is
the activation of caspase cascade, in which series of cysteinyl
aspartic acid speciﬁc proteases get activated by cleavage of their
zymogen form and this leads to the activation of two main
pathways of apoptosis: the extrinsic death receptor mediated
and intrinsic mitochondrial mediated apoptosis. Caspase 3 and
7, which are also known as eﬀector caspases gets activated in
both the pathways, while caspase 8 and caspase 9 (initiator
caspases) are involved only in extrinsic and intrinsic pathways,
respectively, (Patil et al., 2010). Caspase 3 activation induces
PARP cleavage, DNA fragmentation and ultimately kills the cells
by apoptosis.
We further conﬁrmed the anticancer activity of GM by
treatment of DLA induced mice with GF, GB, and GL methanol
extracts. In judgment of anticancer activity of a drug, the
prolongation ILS of the animals and the decrease of leukemic
cells from blood is considered as reliable criteria (Gupta et al.,
2004). More interestingly, for the ﬁrst time, we found that the
DLA bearing mice administered with 100 mg/kg and 200 mg/kg
of GF prolonged the life span of the animals signiﬁcantly than the
untreated group. Decrease in viable DLA cell count in GF treated
group of animals compared to the untreated group indicates that
the test drug is having in vivo anti proliferative activity on DLA
cells. Similar studies have been reported Augustine et al. (2014),
where they found that the ethyl acetate fraction of Leucas aspera
signiﬁcantly reduced the viable DLA cell count on treatment
of DLA induced mice with it. The anticancer property of the
G. morella can also be attributed by its in vitro cytotoxic property
as evidenced by its in vitro activity (Loganayaki and Manian,
2012).
The tumor control group wasmarked by increase inWBC and
decrease in RBC count. It is found from our results that treatment
with GF extract could restore the hematological parameters in the
GF treated groups. In this case it can be postulated that due to
progression of cancer, WBC levels increased in the DLA induced
animals. On treatment with the GF extract, the WBC and RBC
levels were signiﬁcantly restored.
Several studies have reported that on induction of cancer in
experimental animals, cause damage to the vital organs, such as
liver and kidney. ALP levels rises in plasma on obstruction of
large bile duct, intra hepatic cholestasis or inﬁltrative diseases of
the liver (Harada et al., 1986). In the present study it was observed
that DLA bearing mice showed higher levels of serum AST, ALT,
and ALP levels and severe damage to the hepatocytes. GF extract
signiﬁcantly restored the serum enzyme levels and protects the
hepatocytes of DLA bearing mice.
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FIGURE 7 | (A) Fold change in in vivo DLA cell death measured by FACS analysis of DLA cells aspirated from the different in vivo experimental group after staining
with PI. (B1,2) are pictures of DLA induced untreated and GF 200 mg/kg treated mice after 10 days of drug treatment. (C1–3) represents the fluorescent microscope
images of DLA cells aspirated from the untreated, standard treated and GF200 mg/kg treated in vivo experimental groups after staining with PI. (C4) is a zoomed
image from (C3) showing apoptotic morphology of GF 200 mg/kg treated group.
Tumor cells growing in in vivo condition are in a hypoxic
state (Koiri et al., 2009). This activates hypoxia inducible factor
1α (HIF-1α) and this may lead to initiation of angiogenesis by
activation of downstream genes, such asVEGF (Zhao et al., 2015).
There is evidence that standard drug such as cyclophosphamide
has antiangiogenic activity in cancer induced animal model
(Colleoni et al., 2002). GF (200 mg/kg) signiﬁcantly inhibited
the growth of new blood vessels in the tumor area. Thus,
it can be hypothesized that GF extract may have inhibited
hypoxia inducible factors or in the downstream of the pathway,
which ultimately led to successful inhibition of angiogenesis.
Further molecular study in this regard may lead to successful
identiﬁcation of the exact mechanism of action of GF on
angiogenesis.
CONCLUSION
The current study could clearly reﬂect the highly antioxidant and
anticancer eﬃcacy of methanol extract of fruits of G. morella.
Its ability to increase the longevity of DLA induced mice and
restore their hematological and biochemical parameters was quite
signiﬁcant. This study also suggests that the cytotoxic eﬀect of GF
on DLA is due to induction of caspases and DNA fragmentation,
which ﬁnally led to apoptosis of the DLA cells. In addition the
anti angiogenic evaluation of GF on DLA suggests the inhibition
of angiogenic mediators like VEGF. Considering the ﬁndings of
this study, it seems quite possible that G. morella fruits may lead
to the development of new anticancer and anti angiogenic drug
in the near future.
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